Prostate cancer cases spike in this US state as doctors share likely reason
Cases of prostate cancer are on the rise in California, according to new research.
A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.
The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the JAMA-published research revealed.
Common Cancer Type Could Be Detected With New Blood Test
Although cases rose, prostate cancer mortality rates declined 2.6% per year from 2004 to 2012, and plateaued from 2012 to 2021. These trends were similar across age, race, ethnicity and region, the researchers found.
The rising cases correspond with a change in guidelines for PSA (prostate-specific antigen) testing, in which the U.S. Preventative Services Task Force (USPSTF) stopped recommending the screenings in 2012, according to the UCSF press release.
Read On The Fox News App
The guidelines were changed in order to reduce the number of prostate cancer patients who were treated with "potentially harmful interventions" for non-threatening forms of the disease.
Men's Cancer Deaths Expected To Spike More Than 90% By 2050, Study Finds
According to UCSF, prostate cancer is the most common cancer among men and the second-leading cause of cancer deaths.
Most prostate cancer tumors, however, are low-grade and "never spread" — and the PSA screening "does not differentiate between aggressive or non-aggressive tumors, leading many men to be diagnosed with cancers that would not hurt them in the long run," the release stated.
"On the other hand, if screening isn't done, timely diagnosis of more advanced cancers can be missed – those cancers might have been successfully treated if found early," UCSF noted.
The freeze in screenings "unfortunately may have led to one of the largest subsequent rises in incidence of distant stage disease," according to the researchers.
UCSF wrote that these findings "reinforce the need for screening that can identify potentially fatal tumors without raising false alarms about ones that pose no threat to the patient."
"Figuring out the best way to screen for prostate cancer continues to be a challenge for researchers and doctors," lead study author Dr. Erin L. Van Blarigan, UCSF associate professor of epidemiology, biostatistics and urology, said in a statement.
Click Here To Sign Up For Our Health Newsletter
"Without screening, the number of men diagnosed with advanced prostate cancer – when treatments are less effective – increases fast."
Fox News senior medical analyst Dr. Marc Siegel, who was not involved in the study, also called out the need for regular screenings.
For more Health articles, visit www.foxnews.com/health
"[Screenings] decreased in many areas, including California, as the U.S. Preventive Services Task Force recommended against PSA as a regular screening tool, which I always disagreed with," he told Fox News Digital. "Especially as MRI advanced, so not all elevated PSA automatically meant a biopsy."
Based on the increase in prostate cancer cases across all ages, Siegel emphasized the need to "diagnose it early for better outcomes."
Siegel suggested that the increase in cases could also be due to a variety of factors, including the obesity epidemic, ultraprocessed foods and an increase in alcohol consumption and fatty foods.
David R. Wise, MD, PhD, urologic oncologist and the service chief of the Genitourinary Medical Oncology Program at NYU Langone Perlmutter Cancer Center, also reacted to this rise in cases.
"The increasing incidence of metastatic prostate cancer in California in the 2010s is consistent with reports by others, including the American Cancer Society," Wise, who was not involved in the research, told Fox News Digital.
"It likely reflects the aftermath of diminished prostate cancer screening. A return to prostate cancer screening will likely reverse this effect."
"Optimized screening, enhanced by MRI and novel blood-based biomarkers, is now available and is poised to spare men with low risk disease from unnecessary treatment while ensuring early detection for men with aggressive cancer," he added.Original article source: Prostate cancer cases spike in this US state as doctors share likely reason
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
9 hours ago
- San Francisco Chronicle
Is forgetting things ‘normal' aging or something worse? Here's first step to finding out
Millions of Americans live with mild cognitive impairment and dementia, and millions more are projected to be diagnosed in the coming years. If you're having memory or cognitive problems, the first thing you should do is get evaluated by your doctor, medical experts said. They stress that not all memory loss and cognitive decline are degenerative or permanent, so it's important to get tested to try to understand the underlying causes of the symptoms and seek the right treatment if applicable. Testing for cognitive decline Many people go first to their primary care physician or geriatrician, who may then refer them to a neurologist. Two widely used tests are the Montreal Cognitive Assessment Test (MOCA) and the Saint Louis University Mental Status Exam. 'If someone is concerned about their memory and thinking, and feel there's a change from their prior baseline, the first step is to talk to their primary care physician,' said Dr. Irina Skylar-Scott, a Stanford neurologist who specializes in memory disorders. 'They can do a basic evaluation and talk to them to see if there could be an issue.' Testing can include taking a detailed history, asking what function was like before and what's changed, and comparing your results with what's expected in people of the same age and education level. Sometimes doctors do additional testing, such as bloodwork and brain imaging. Bloodwork can show if someone has abnormal thyroid function or abnormal vitamin B12 levels, both of which can cause symptoms that mimic dementia. A brain MRI can show whether certain areas have tissue loss in the memory centers of the brain. Because there are so many potential causes of cognitive problems other than dementia — such as depression, stroke, sleep apnea and other diseases — it's important to rule out other medical conditions that could be contributing to dementia-like symptoms. The 3 types of memory loss There are distinct categories of memory and cognition loss, and neurologists and geriatricians generally put them in three buckets: 'Normal aging' is characterized by some memory loss, often short-term, and subtle loss of cognition, especially with things involving speed or multitasking. It may take a little longer, or require a little more effort, to store or recall information. But the cognitive changes don't affect your ability to function day to day. 'As we get older, we tend to have very subtle, often slight declines in certain cognition,' said Dr. Kristine Yaffe, a professor of psychiatry, neurology and epidemiology at UCSF and a leading researcher of cognitive aging. 'That slows down a little bit but doesn't get in the way of what you can do. If you were to be tested, it'd be a mild change.' Many people experience this, and it's not necessarily a medical problem. 'If you compare people in their 30s and 40s, by the time they're in their 70s and 80s, they're going to have small declines,' Yaffe said. 'That'd be 'normal aging.' They're not quite as fast or facile, but it's not anything major and not getting in the way of their functioning.' If you forgot where you parked your car or where you left your glasses or keys, 'those are kind of normal things,' said Dr. Wynnelena Canio, a geriatrician at Kaiser Permanente in San Rafael. 'The most common cause of memory issues is not paying attention. When we park or leave our glasses on the table, a lot of times our mind is somewhere else because we're in a hurry so we didn't store that information to begin with.' Mild cognitive decline (MCI) is a formal diagnosis for which the criterion is demonstrating impairment on at least one cognitive domain — language, memory, executive function, and visual-spatial skills — during testing. Being impaired means you've scored significantly below the norm for your age and education level in that domain. But you're still functioning, for the most part, on your own — though you may rely more on lists to remember things, for instance. 'Usually people have some sort of subjective sense,' Yaffe said. 'Their loved ones will say, 'Yes, they have declined on this.' Sure enough, they don't do as well on testing, but are still functioning OK. It's not enough where it's really getting in the way. They don't remember some things but are still able to do a lot of what they used to be able to do.' MCI can, but does not always progress to dementia. An estimated 10% to 15% of people living with MCI progress to dementia each year, according to the Alzheimer's Association. People with MCI who have certain genetic traits such as APOE4, a variant that increases the risk of Alzheimer's, may be more likely to progress than not, Yaffe said. Dementia involves many symptoms similar to those of MCI. But the main difference is that 'a person with dementia is impaired in function,' said Canio, of Kaiser. 'They need others to help them pay the bills, get them places, get them to their appointments. Once someone is needing assistance from someone else to do some of those things, it's a warning sign it could be dementia.' How quickly dementia may progress — from mild to moderate or severe — is not clear. But the biggest predictor is what someone's trajectory has been to date, said Skylar-Scott, of Stanford. 'A patient with early onset before age 65 will progress much more quickly than patients with late onset,' she said.
Newsweek
a day ago
- Newsweek
Parents Welcome Baby Boy, 3 Months Later Realize Something Is Wrong
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A woman has revisited the moment she began to suspect something wasn't right with her newborn son and the emotional journey that followed as she sought to find answers. Carli Cowie from Moray in Scotland, took to her TikTok account, Carlirose33, to share pictures of Noah from when he was born on November 3, 2018 and in the blissful days that followed. "The best day of my life," Cowie wrote alongside the images. "I couldn't stop staring at him. I couldn't believe this beautiful baby was ours. Our hearts were so full of love." By the time Noah's six-week check-up rolled around, everything seemed to be on track. "He was hitting milestones," Cowie said. But by 12 weeks, Cowie and her husband had started to notice "something wasn't right." Cowie told Newsweek: "He wasn't making eye contact with us, wasn't following toys and his eyes were wobbling." Carli first noticed an issue with Noah's eyes when he was just 12 weeks old. Carli first noticed an issue with Noah's eyes when he was just 12 weeks old. TikTok/carlirose33 They made an appointment for Noah to see their doctor, who then referred them on to an ophthalmologist. At this point, there were concerns Noah could have retinoblastoma, a rare type of cancer affecting the retina. Read more Woman remembers one thing dad "regretted"—30 years later she makes it right Woman remembers one thing dad "regretted"—30 years later she makes it right In order to find out if this was the case, doctors needed to dilate his pupils to check. All this time, Cowie and her husband were left facing an anxious wait for answers. "We were so worried and didn't know what the outcome was going to be," she said. She estimates it took three months from that initial doctor's appointment, for them to get an understanding of Noah's condition. Doctors suspected Noah had been born with optic nerve hypoplasia, meaning his optic nerves were under-developed. The "wobbling" movement his eyes made was also thought to be a result of nystagmus, an involuntary eye movement condition that further reduces or limits vision. A delayed MRI scan eventually confirmed the heartbreaking diagnosis: Noah was blind. His parents were left in shock at the news. "We were devastated and in disbelief that this was happening to our baby," Cowie said. "We initially thought it wouldn't be something as serious as what it was, we thought he'd maybe need glasses or something along those lines." Though Cowie was rocked by the news, she managed to stay strong, with the support of her husband and family, knowing it was important to maintain a happy household for Noah's sake. "I didn't want Noah to pick up if we were upset so I always tried to be in high spirits for him," she said. "Although he was blind I kept reminding myself that he was healthy and we were grateful for that." Noah underwent regular check-ups in the years that followed with doctors careful to monitor that his weight and height was within the normal range. "If the tests weren't in normal range he would have been put on growth hormone injections until he was 18," Cowie said. Thankfully, for Noah, that wasn't needed and by the time he turned 4, he was fully discharged and ready to his way as a blind child out in the world. He's not alone in that respect. In the U.S., the CDC estimates nearly 3 percent of children under the age of 18 have blindness or vision impairment. Noah Cowie is 6 and thriving now. Noah Cowie is 6 and thriving now. TikTok/carlirose33 It's a life that comes with its own unique challenges for his mom and dad. "One of the biggest I would say is his safety and making sure there is nothing in his way or lying out for him to trip over or bump into," Cowie said. But it is one that Noah, now 6, is thriving in, with a little help from mom, dad and his two-year-old sister Ocean. "He's doing really well. Noah is always keen to try new things and we are amazed with how well he gets on," Callie said. "He's a clever boy and enjoys learning. He's at the early stages of learning braille and learning to use his cane with support." Callie's TikTok video, chronicling their journey with Noah went viral, amassing over 640,000 views since being posted earlier this month. She's incredibly proud of her son and hopes this video and others like it help any families who may be going through similar situations with a young child. Noah's story isn't one of heartbreak, it's one of hope. "I wanted to show everyone how amazing he is," Callie said. "Being blind hasn't stopped him from doing anything."
San Francisco Chronicle
2 days ago
- San Francisco Chronicle
There's been a stunning drop in heart attack deaths — but these other risks are rising
Deaths from heart attacks have fallen dramatically over the past 50 years, even taking into account a short but sharp increase in mortality during the COVID-19 pandemic, in a testament to the remarkable medical investment made by the U.S. to counteract a deadly public health threat, say teams of scientists from UCSF and Stanford who released parallel reports this week. Heart attack deaths dropped by nearly 90% from 1970 to 2022, the time period that the Stanford team studied for their report published in the Journal of the American Heart Association. That's a direct result of immense investment in tools to prevent, test for and treat cardiovascular conditions, in particular heart attacks, said Dr. Latha Palaniappan, senior author of the Stanford paper. 'A 90% reduction in heart attack deaths over the last 50 years is nothing short of a medical miracle,' Palaniappan said. In the paper, Palaniappan and her peers noted that nearly half of global funding for heart disease research comes from the U.S., which 'has had an incredible return on investment.' 'This investment has driven global breakthroughs and continues to shape how we prevent and treat heart disease worldwide,' Palaniappan said. 'These breakthroughs have helped increase life expectancy in the U.S. by a full decade since the 1970s.' On the other hand, progress has flagged in fighting deaths from other types of cardiovascular issues, including high blood pressure, heart failure and arrhythmia, according to both studies. Overall cardiovascular mortality from non-heart attacks increased by about 80% over the past 50 years. Both the Stanford and UCSF studies analyzed heart disease deaths using data from the Centers for Disease Control and Prevention. The studies noted sharp increases in heart attack deaths during the pandemic — peaking at about 93 of every 100,000 deaths in 2021 — that have since fallen to pre-pandemic levels. Heart disease has been the leading cause of death among Americans for more than a century. The term describes a wide range of conditions, including coronary artery disease, the main contributor to heart attacks, along with heart failure, heart rhythm disorders and hypertension. The drop in heart attacks comes from a multi-pronged effort, including public health campaigns such as smoking cessation efforts, and medical advances in prevention and treatment. According to the Stanford study, someone over age 65 who was hospitalized for a heart attack in 1970 had a 60% chance of leaving the hospital alive; today, they have a greater than 90% chance. But the drop in heart attacks has coincided with an increase in deaths caused by all other heart conditions. The UCSF study found that deaths from high blood pressure doubled from 1999 to 2023, the time period the scientists analyzed. Deaths from heart failure also climbed, hitting a record high in 2023. Part of the reason deaths from other types of heart disease are climbing is because people are generally living longer — the age expectancy increased by about a decade over the past 50 years. They're surviving heart attacks and then succumbing later to other, sometimes related conditions. Dr. Sanket Dhruva, senior author of the UCSF paper, said these conditions are all treatable and preventable. He said the data should compel the medical community to redouble efforts to battle all types of heart conditions — the immense progress made against heart attacks demonstrates what can be done with money and focus, Dhruva said. 'Really one of the key findings of our paper is where have the patterns been worsening,' Dhruva said. 'Death from cardiovascular disease is getting better over time, but it's not that simple. It's very nuanced. Death from hypertension diseases, and related to heart failure — those deaths are reaching record highs.' Dhruva said that for many of these conditions, tools already exist to improve outcomes for most patients — the work needs to focus on making sure those tools are accessible, and that the people who need them are being diagnosed and connected to treatment. For example, the U.S. needs to do a better job of screening for high blood pressure, then making sure people with high blood pressure have access to health care providers, medication and testing equipment. The UCSF paper found a precipitous increase in heart disease deaths during the pandemic, in large part because people's access to care was interrupted — folks stopped visiting their doctors, checking their blood pressure or even taking their medications. Some people stopped exercising, further increasing their risk. Though that care is getting back on track for most people, its absence should demonstrate how critical it is to maintain access. 'The pandemic halted decades of progress,' the UCSF paper noted. 'We know that people were not coming for care, we know that risk factors got worse,' Dhruva said. 'People gained weight, medication adherence slipped, people stopped seeing their care providers as often. Cardiovascular care got worse during the pandemic.' Still, he said, 'We learned a lot from the pandemic. We learned that it's absolutely necessary to ensure that patients are getting care.'
